Skip to main content
. 2018 Sep 24;8:14244. doi: 10.1038/s41598-018-32652-3

Figure 4.

Figure 4

RSPO2 fusion PDX tumor growth inhibition by CGX1321. (a) GA3055, CR3056, GA007 and GA108 PDX xenograft mouse models were treated with 1 ml/kg vehicle formulation or 1 mg/kg CGX1321, p.o., QD for 21, 25 and 28 days respectively (N = 6). (b) Axin2 mRNA levels detected by quantitative RT-PCR 7 hours after final dosing (N = 4), **p < 0.01, ***p < 0.001. (c) Alcian blue staining of the vehicle and treated GA007 tumor samples. GA007 PDX xenograft mouse models were treated with 1 ml/kg vehicle formulation or 1 mg/kg CGX1321 for 27 days. left: vehicle group; right: treatment group. Scale bar is 50 μm.